A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines

Biomaterials

Volumn 30, Issue 25, 2009, Pages 4168-4177

  Acharya, Abhinav P ^a   Clare Salzler, Michael J ^b   Keselowsky, Benjamin G ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Dendritic cell; High throughput; Microarray; Microparticle; Miniarray; Vaccine

Indexed keywords

ADHESIVE SURFACES; ALIGNMENT ERROR; AUTOIMMUNE DISEASE; CELL MIGRATION; CELL POPULATIONS; COLOCALIZATION; CONTACT PRINTING; CROSS CONTAMINATION; D , L-LACTIDE; DELIVERY SYSTEMS; DENDRITIC CELL; DENDRITIC CELLS; GLYCOLIDE; HIGH FIDELITY; HIGH-THROUGHPUT; IMMUNE CELLS; IMMUNE SYSTEMS; IMMUNOTHERAPEUTICS; IN-VIVO; ISOLATED ISLANDS; KEY REGULATORS; MICRO-PARTICLES; MICROPARTICLE; MINIARRAY; MULTIPARAMETER; NEW CLASS; PIN DIAMETERS; RATIONAL DESIGN; RELEASE PROPERTY; SURFACE MODIFICATION; TWO-COMPONENT;

AMINES; CELL CULTURE; CELL PROLIFERATION; CONTROLLED DRUG DELIVERY; DENDRIMERS; IMMUNOLOGY; OPTIMIZATION; PROTEINS; TARGETS; THROUGHPUT;

VACCINES;

AMINE; DRUG CARRIER; IMMUNOLOGICAL ADJUVANT; MACROGOL; NANOPARTICLE; POLOXAMER; POLYGLACTIN; SILANE; VACCINE;

ADSORPTION; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; CHEMICAL MODIFICATION; CONTROLLED STUDY; DEGRADATION KINETICS; DENDRITIC CELL; DRUG CONTAMINATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; ELECTRONICS; ENCAPSULATION; HIGH THROUGHPUT SCREENING; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; MICROARRAY ANALYSIS; MOUSE; NEWBORN; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; LACTIC ACID; MATERIALS TESTING; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; PARTICLE SIZE; POLYGLYCOLIC ACID; REPRODUCIBILITY OF RESULTS; SURFACE PROPERTIES; VACCINES;

EID: 67649887313     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.04.032     Document Type: Article

References (51)

1. Bromberg L. Intelligent hydrogels for the oral delivery of chemotherapeutics. Exp Opin Drug Deliv 2 (2005) 1003-1013
2. Benoit J.P., Faisant N., Venier-Julienne M.C., and Menei P. Development of microspheres for neurological disorders: from basics to clinical applications. J Control Release 65 (2000) 285-296
3. Gao Y., Gao G., He Y., Liu T., and Qi R. Recent advances of dendrimers in delivery of genes and drugs. Mini Rev Med Chem 8 (2008) 889-900
4. Reddy S.T., Rehor A., Schmoekel H.G., Hubbell J.A., and Swartz M.A. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 112 (2006) 26-34
5. Richards Grayson A.C., Choi I.S., Tyler B.M., Wang P.P., Brem H., Cima M.J., et al. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2 (2003) 767-772
6. dlakha-Hutcheon G., Bally M.B., Shew C.R., and Madden T.D. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol 17 (1999) 775-779
7. Shi L., Caulfield M.J., Chern R.T., Wilson R.A., Sanyal G., and Volkin D.B. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 91 (2002) 1019-1035
8. Tamber H., Johansen P., Merkle H.P., and Gander B. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57 (2005) 357-376
9. Cohen S., Yoshioka T., Lucarelli M., Hwang L.H., and Langer R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 8 (1991) 713-720
10. Elamanchili P., Diwan M., Cao M., and Samuel J. Characterization of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22 (2004) 2406-2412
11. Waeckerle-Men Y., and Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Adv Drug Deliv Rev 57 (2005) 475-482
12. Waeckerle-Men Y., Gander B., and Groettrup M. Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med 109 (2005) 35-46
13. Kempf M., Mandal B., Jilek S., Thiele L., Voros J., Textor M., et al. Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target 11 (2003) 11-18
14. Faraasen S., Voros J., Csucs G., Textor M., Merkle H.P., and Walter E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(l-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res 20 (2003) 237-246
15. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8 + T cell tolerance. J Exp Med 196 (2002) 1627-1638
16. Matzinger P. An innate sense of danger. Semin Immunol 10 (1998) 399-415
17. Medzhitov R., and Janeway Jr. C.A. Innate immune recognition and control of adaptive immune responses. Semin Immunol 10 (1998) 351-353
18. Yoshida M., Mata J., and Babensee J.E. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells. J Biomed Mater Res A 80 (2007) 7-12
19. Babensee J.E. Interaction of dendritic cells with biomaterials. Semin Immunol 20 (2008) 101-108
20. Schlosser E., Mueller M., Fischer S., Basta S., Busch D.H., Gander B., et al. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine 26 (2008) 1626-1637
21. Elamanchili P., Lutsiak C.M., Hamdy S., Diwan M., and Samuel J. Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells. J Immunother 30 (2007) 378-395
22. Phillips B., Nylander K., Harnaha J., Machen J., Lakomy R., Styche A., et al. A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes. Diabetes 57 (2008) 1544-1555
23. Kasturi S.P., Sachaphibulkij K., and Roy K. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 26 (2005) 6375-6385
24. Jilek S., Merkle H.P., and Walter E. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 57 (2005) 377-390
25. Jilek S., Zurkaulen H., Pavlovic J., Merkle H.P., and Walter E. Transfection of a mouse dendritic cell line by plasmid DNA-loaded PLGA microparticles in vitro. Eur J Pharm Biopharm 58 (2004) 491-499
26. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
27. Flaim C.J., Chien S., and Bhatia S.N. An extracellular matrix microarray for probing cellular differentiation. Nat Methods 2 (2005) 119-125
28. El-Ali J., Sorger P.K., and Jensen K.F. Cells on chips. Nature 442 (2006) 403-411
29. Soen Y., Mori A., Palmer T.D., and Brown P.O. Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments. Mol Syst Biol 2 (2006) 37
30. Newman K.D., Samuel J., and Kwon G. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J Control Release 54 (1998) 49-59
31. Garcia A.J., Vega M.D., and Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell 10 (1999) 785-798
32. Acharya A.P., Dolgova N.V., Clare-Salzler M.J., and Keselowsky B.G. Adhesive substrate-modulation of adaptive immune responses. Biomaterials 29 (2008) 4736-4750
33. Amiji M., and Park K. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers. Biomaterials 13 (1992) 682-692
34. Tan J.L., Liu W., Nelson C.M., Raghavan S., and Chen C.S. Simple approach to micropattern cells on common culture substrates by tuning substrate wettability. Tissue Eng 10 (2004) 865-872
35. Watts C. Phagosome neutrality in host defense. Cell 126 (2006) 17-19
36. Goraltchouk A., Scanga V., Morshead C.M., and Shoichet M.S. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J Control Release 110 (2006) 400-407
37. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
38. Giannoukakis N., Phillips B., and Trucco M. Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond. Pediatr Diabetes 9 (2008) 4-13
39. Waeckerle-Men Y., Allmen E.U., Gander B., Scandella E., Schlosser E., Schmidtke G., et al. Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine 24 (2006) 1847-1857
40. Brannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56 (2004) 1649-1659
41. Gref R., Quellec P., Sanchez A., Calvo P., Dellacherie E., and Alonso M.J. Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers. Eur J Pharm Biopharm 51 (2001) 111-118
42. Herrmann J., and Bodmeier R. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm 45 (1998) 75-82
43. Schepers E.J., and Ducheyne P. Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil 24 (1997) 171-181
44. Silva G.A., Ducheyne P., and Reis R.L. Materials in particulate form for tissue engineering. 1. Basic concepts. J Tissue Eng Regen Med 1 (2007) 4-24
45. Yang Y.Y., Shi M., Goh S.H., Moochhala S.M., Ng S., and Heller J. POE/PLGA composite microspheres: formation and in vitro behavior of double walled microspheres. J Control Release 88 (2003) 201-213
46. Jiang G., Qiu W., and DeLuca P.P. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm Res 20 (2003) 452-459
47. Yan X., and Gemeinhart R.A. Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles. J Control Release 106 (2005) 198-208
48. Redding T.W., Schally A.V., Tice T.R., and Meyers W.E. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules. Proc Natl Acad Sci U S A 81 (1984) 5845-5848
49. Adamczyk Z., Jaszczolt K., Michna A., Siwek B., Szyk-Warszynska L., and Zembala M. Irreversible adsorption of particles on heterogeneous surfaces. Adv Colloid Interface Sci 118 (2005) 25-42
50. Bailey S.N., Ali S.M., Carpenter A.E., Higgins C.O., and Sabatini D.M. Microarrays of lentiviruses for gene function screens in immortalized and primary cells. Nat Methods 3 (2006) 117-122
51. Anderson D.G., Levenberg S., and Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 22 (2004) 863-866